id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0662-0007,FDA,FDA-2010-E-0662,Notice of Final Determination,Other,Background Material,2013-12-05T05:00:00Z,2013,12,2013-12-05T05:00:00Z,,2013-12-05T19:28:26Z,,0,0,09000064814a8937
FDA-2010-E-0662-0006,FDA,FDA-2010-E-0662,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T19:53:47Z,,0,0,090000648119cadb
FDA-2010-E-0662-0005,FDA,FDA-2010-E-0662,Regulatory Review Period for Purposes of Patent Extension: JEVTANA,Notice,General Notice,2012-05-04T04:00:00Z,2012,5,2012-05-04T04:00:00Z,2012-07-04T03:59:59Z,2012-05-04T14:10:47Z,2012-10828,0,0,0900006481004c87
FDA-2010-E-0662-0004,FDA,FDA-2010-E-0662,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-04-18T04:00:00Z,2012,4,2012-04-18T04:00:00Z,,2012-04-18T14:44:52Z,,0,0,0900006480ff398e
FDA-2010-E-0662-0003,FDA,FDA-2010-E-0662,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,Letter(s),2012-01-10T05:00:00Z,2012,1,2012-01-10T05:00:00Z,,2012-01-10T15:39:45Z,,0,0,0900006480f91f3f
FDA-2010-E-0662-0001,FDA,FDA-2010-E-0662,Aventis Pharma S.A. - Patent Term Extension Application,Other,APP-Application,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-07-27T23:41:23Z,,0,0,0900006480bc2a98
FDA-2010-E-0662-0002,FDA,FDA-2010-E-0662,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-08-11T01:39:02Z,,0,0,0900006480bc2a9a